
Please try another search
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. In addition, it provides Sunrise, a bio-signal to diagnose sleep apnea. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Name | Age | Since | Title |
---|---|---|---|
Gaetano Alfred-Gerrard Russo | 61 | 2020 | Chairman of the Board |
Peter A. Cistulli | - | - | Chairman of the Medical Advisory Board |
Karen Borg | - | 2020 | Co-CEO & Executive Director |
Iven Klineberg | - | - | Member of the Medical Advisory Board |
J. A. Gerschman | - | - | Member of the Medical Advisory Board |
Michael Gordon | 58 | 2020 | Non-Executive Director |
Benjamin Gisz | 47 | 2024 | Non-Executive Director |
Andrew Martin Price | - | 2025 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review